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Alzheimer is characterized by the presence of senile plaques and neuroﬁbrillary tangles in cortical regions of the brain. The
experimental data is taken from Gene Expression Omnibus. A hierarchical Cluster analysis and TreeView were performed to
group genes on the basis of the expression pattern. The dynamic change of expression over time and diverse patterns of expression
support the concept of a complex local milieu. TreeView allows the organized data to be visualized. List of 24 genes were obtained
which showed high expression levels. Three genes, SORL1, APP, and APOE, are suspected to cause Alzheimer’s whereas the other
21 genes are related to other diseases but may also be found to be associated with Alzheimer’s, and these are TMEM59, CCT4,
IGF2R, SFPQ, PRDX3, RNF14, IDS, SSBP1, SYNE2, TXNL4A, STXBP3, SMARCB1, ULK2, AGTPBP1, FABP7, CALB1, H2AFY,
COPA, SAP18, ATIC and SYNCRIP.
1.Introduction
The brain accumulation of a neurotoxic proteolytic deriva-
tive of the amyloid precursor protein (APP) is the essential
eventinthepathogenesisofAlzheimer’sdisease(AD)leading
to neuronal loss [1]. Alzheimer’s disease brain pathology is
also characterized by the formation of intraneuronal tau-
associated neuroﬁbrillary tangles, which cause additional
neurotoxic insult since mutations in the MAPT gene encod-
ing the tau protein are responsible for frontotemporal
dementia [2]. The accumulation of neuroﬁbrillary tangles is
afeatureofseveralneurodegenerativediseases.Insomecases,
this accumulation is a primary disease-causing event.
Approximately 5–10% of patients develop an early age-
at-onset AD (before 65 years). The disease in up to 50% of
such cases is explained by mutations in one of three genes:
APP [3], presenilin 1 (PS1) [4], and presenilin 2 (PS2) [5].
Pathological mutations in these genes are responsible for an
autosomal dominant trait and cause A-beta accumulation
in the brain [1]. However, the pathological consequence of
some mutations detected in small AD families is uncertain
and needs further investigation and proposed a systematic
algorithm to classify mutations in known AD genes as
possibly, probably, or deﬁnitely pathogenic [6].
The genetics underlying the common late-onset form of
ADiscomplex.TheapolipoproteinEgene(APOE)isamajor
and well-replicated risk factor for both sporadic and familial
late-onset AD [7].
People who inherit mutated APP, PS1, or PS2 genes are
very likely to develop Alzheimer’s disease at some point in
their lives. These genes are considered predictive. However,
other genes also exist and that can only inﬂuence a person’s
susceptibility to Alzheimer’s disease, but do not mean that
a person is more likely than not to develop the disease. The
best studied of these is apolipoprotein E (APOE). APOE has
functions throughout the body in transporting cholesterol,
regulating the immune system, aiding in nerve regeneration,
and metabolism.
The environmental or genetic factors are also required
in order for a person to develop Alzheimer’s. Genetic testing
for the APOE gene is not recommended for healthy people.
However, it may be a useful diagnostic test in someone with
dementia.2 International Journal of Alzheimer’s Disease
Cluster analysis of DNA microarray data is described
as statistical algorithms to arrange the genes according to
similar patterns of gene expression, and the output has
been displayed graphically. Hierarchical clustering is a mul-
tivariate tool often used in phylogenetics and comparative
genomics to relate the evolution of species [8].
Cluster and TreeView are programs that provide a com-
putational and graphical environment for analyzing data
from DNA microarray experiments or other genomic data-
sets. The program Cluster can organize and analyze the data
in a number of diﬀerent ways. TreeView allows the organized
datatobevisualizedandbrowsed.Thismanualisintendedas
areferenceforusingthesoftwareandnotasacomprehensive
introductiontothemethodsemployed.Manyofthemethods
are drawn from standard statistical Cluster analysis.
Independent Component Analysis as a microarray data
analysis tool can also help to elucidate the molecular taxon-
omy of AD and other multifactorial and polygenic complex
diseases [9].
2.MaterialandMethods
Cluster and TreeView are programs that provide a compu-
tational and graphical environment for analyzing data from
DNA microarray experiments or other genomic datasets.
The program Cluster can organize and analyze the data in
an u m b e ro fd i ﬀerent ways. TreeView allows the organized
data to be visualized and browsed.
Gene expression omnibus is a tool in NCBI where the
data was taken. Each sample has its own accession number.
The accession number can either start with GSD or GSM
followed by the number. The other format is not accepted by
the tool. Gene expression omnibus consist of samples in tab-
delimited form which either opens in note pad or Microsoft
excel.
The microarray data is downloaded from http://bioin-
formatics.oxfordjournals.org/ from the database-wide ex-
pression proﬁle for individual genes, and it is possible to
standardize individual gene expression intensities in a spe-
ciﬁc assay by using their unique database-wide means and
standard deviations. This consideration of gene’s behavior
in a wide variety of biological conditions gives new insight
into interpreting the expressional diﬀerence between given
samples. In a biological point of a view, the expressional dif-
ference of a gene with a small database-wide expressional
variation should have more attention than those with large
database-wide variations.
TreeView is a program that allows interactive graphical
analysis of the results from Cluster. TreeView reads in match-
ing “∗.cdt” and “∗.gtr,” “∗.atr,” “∗.kgg,” or “∗.kag” ﬁles pro-
duced by Cluster. We recommend using the Java TreeView,
which is based on the original TreeView.
The sample consists of both normal and abnormal
neurons which upon running in Cluster gives the ﬁnal
output. The ﬁnal output we get has ∗CDT, ∗ATR, and ∗GTR
ﬁle extensions. ∗ATR and ∗GTR are automatically accepted
in TreeView while choosing ∗CDT ﬁle type.
Upon loading the ﬁle in Cluster software, the ﬁle is run
in the software to get the output. The output is then run in
TreeView software, and the result is obtained.
3. Result
Cluster Analysis Reveals Distinctive Gene Expression Pat-
terns, Figure 1, shows the analysis of entorhinal cortex
neurons containing neuroﬁbrillary tangles from 10 midstage
Alzheimer’s disease (AD)patients and their comparison with
histopathologically normal neurons from the same patients
and brain region. Results provide insight into the formation
of NFTs in AD.
Twenty-six thousand and ninety-seven genes were clus-
tered hierarchically into groups on the basis of the similarity
of their expression proﬁles and magnitudes by the procedure
of Eisen et al. [8]. The expression pattern of each gene is
displayed here as a horizontal strip. For each gene, the ratio
of mRNA levels in the normal neuron at the indicated time
point to its level in the neuroﬁbrillary tangled tissue is pre-
sented by a color. Red indicates that the gene is upregulated
in comparison to the control, whereas green indicates the
opposite. Sets of genes that clustered together were either
repressed or induced at diﬀerent stage.
Out of twenty-six thousand and ninety-seven genes,
there were three genes which showed abrupt increase in ex-
pression. The three genes are SORL1, APP, and APOE genes.
S O R L 1g e n ei san e u r o n a ls o r t i n gr e c e p t o ra n di sg e n e t -
ically associated with Alzheimer’s disease. SORL1 has a key
physiological role in the diﬀerential sorting of APP holopro-
tein. The recycling of APP from the cell surface via the endo-
cytic pathways plays a key role in the generation of A-beta
peptides, and when SORL1 is underexpressed, more APP
protein is sorted into A-beta-generating compartment [10].
The APP gene encodes a transmembrane precursor pro-
tein involved in nuclear signalling and has multiple isoforms
generated by alternative splicing. APP could be cleaved by
alpha, beta, and gamma secretases. The cleavage by the beta
and gamma secretases leads to the formation of A-beta
peptides—the basis of the amyloid plaques in AD brains,
while the alpha secretase generates soluble not amyloido-
genic APP fragments. The brain accumulation of a neuro-
toxic proteolytic derivative of the amyloid precursor protein
(APP) (A-beta 40/42 peptides) is the essential event in the
pathogenesisofAlzheimer’sdisease(AD)leadingtoneuronal
loss. The apolipoprotein E gene (APOE) is a major and well-
replicatedriskfactorforbothsporadicandfamiliallate-onset
AD [7].
Inspiteoftheabovethreegenes,therewereothertwenty-
one genes related to other diseases but may also be found
to be associated with Alzheimer’s; these are transmembrane
protein 59 [11], chaperonin containing TCP1 subunit 4
(delta) [12], insulin-like growth factor 2 receptor [13], splic-
ing factor proline/glutamine-rich [14], peroxiredoxin 3
[15], ring ﬁnger protein 14 [16], iduronate 2-sulfatase
[17], single-stranded DNA-binding protein 1 [18], spectrin
repeat containing, nuclear envelope 2, thioredoxin-like 4A
[19], syntaxin-binding protein 3 [20], SWI/SNF-related,
matrix-associated, actin-dependent regulator of chromatin,International Journal of Alzheimer’s Disease 3
Table 1: List of genes of high expression in microarray data.
AFFYMETRIX 3PRIME IVT ID Gene name Disease caused
200620 at Transmembrane protein 59 Alzheimer’s disease
200877 at Chaperonin containing TCP1, subunit 4 (delta) Hereditary sensory neuropathy
201393 s at Insulin-like growth factor 2 receptor Parkinson’s disease
201586 s at Splicing factor proline/glutamine-rich (polypyrimidine
tract-binding protein associated) Papillary renal cell carcinoma
201619 at Peroxiredoxin 3 Oxidative stress to cells—Alzheimer’s
and Parkinson’s disease
201823 s at Ring ﬁnger protein 14 Insulin Resistance Syndrome
202438 x at Iduronate 2-sulfatase Hunter syndrome
202591 s at Single-stranded DNA-binding protein 1 Crown gall disease
202761 s at Spectrin repeat containing, nuclear envelope 2 Cerebellar ataxia type 1
202836 s at Thioredoxin-like 4A Niemann-Pick disease
203310 at Syntaxin-binding protein 3 Cardiovascular disease
203874 s at SWI/SNF related, matrix-associated, actin-dependent
regulator of chromatin, subfamily a, member 1 Autosomal recessive pleiotropic disorder
204063 s at unc-51-like kinase 2 (C. elegans) Polycystic kidney disease
204500 s at ATP/GTP-binding protein 1 Musculoskeletal disease
205029 s at Fatty-acid-binding protein 7, brain Coronary disease
205626 s at Calbindin 1, 28kDa Parkinson’s disease
207168 s at H2A histone family, member Y Ataxia-Telangiectasia
208684 at coatomer protein complex, subunit alpha Protein energy malnutrition
208742 s at Sin3A-associated protein, 18kDa Huntington’s disease
208758 at 5-Aminoimidazole-4-carboxamide ribonucleotide
formyltransferase/IMP cyclohydrolase Non-Hodgkin’s lymphoma
209025 s at Synaptotagmin-binding, cytoplasmic RNA-interacting
protein Alzheimer’s disease
Figure 1: Cluster TreeView.4 International Journal of Alzheimer’s Disease
subfamily a, member 1, unc-51-like kinase 2 (C. elegans),
ATP/GTP-binding protein 1, fatty-acid-binding protein 7,
brain [21], calbindin 1, 28kDa [22], H2A histone family,
member Y [23], coatomer protein complex, subunit alpha
[12], Sin3A-associated protein, 18kDa [24], 5-aminoimid-
azole-4-carboxamide ribonucleotide formyltransferase/IMP
cyclohydrolase, and synaptotagmin-binding, cytoplasmic
RNA-interacting protein [25] twenty-one genes which
showed high expression level, and the genes are listed in
Table 1.
4. Conclusion and Discussion
We have focused on presenting an overview of hierarchical
clustering of microarray data, emphasizing the relationship
between a dendrogram and spatial representations of genes.
We believe this relationship provides an intuitive under-
standing of how to analyze microarray data and can make
it easier to interpret the results of a Cluster analysis in a
biological framework. The fact that the “heat maps” found
in the majority of microarray publications are based on
hierarchicalclusteringindicatesthatanunderstandingofthis
general method is valuable to those who are just beginning
to read the microarray literature and even to those who are
using supervised methods. We have used Cluster analysis
software which is available online at Eisen laboratories and
the version is Cluster 3.0.
According to Kong et al. [9], independent component
analysis may contribute to a deeper understanding of gene
expression data. Particularly, ICA resolves expression data
at a higher resolution than is achieved by approaches based
on correlations alone, even though the aim of the present
investigation was not to evaluate speciﬁc ICA algorithms and
procedures for analyzing microarray data. However, choos-
ing the appropriate algorithms for analysis is a crucial ele-
ment of the experimental design and will aﬀect the type of
information that is retrieved. In the present study of hier-
archical clustering, we concentrated on identifying the bio-
marker genes associated with Alzheimer’s from the microar-
ray data.
Identiﬁcation of candidate genes could provide easily
accessible biomarkers to monitor Alzheimer’s, and these are
SORL1, and APP, and APOE, the other 21 genes listed are
related to other diseases but may also be found to be associ-
ated with Alzheimer’s; these are transmembrane protein 59
[11], chaperonin containing TCP1 subunit 4 (delta) [12],
insulin-like growth factor 2 receptor [13], splicing factor
proline/glutamine-rich [14], peroxiredoxin 3 [15], ring
ﬁnger protein 14 [16], iduronate 2-sulfatase [17], single-
stranded DNA-binding protein 1 [18], spectrin repeat con-
taining, nuclear envelope 2, thioredoxin-like 4A [19], syn-
taxin-binding protein 3 [20], SWI/SNF-related, matrix-
associated, actin-dependent regulator of chromatin, subfam-
ily a, member 1, unc-51-like kinase 2 (C. elegans), ATP/GTP-
binding protein 1, fatty-acid-binding protein 7, brain [21],
calbindin 1, 28kDa [22], H2A histone family, member Y
[23], coatomer protein complex, subunit alpha [12], Sin3A-
associatedprotein,18kDa[24],5-aminoimidazole-4-carbox-
amideribonucleotideformyltransferase/IMPcyclohydrolase,
and synaptotagmin-binding, cytoplasmic RNA-interacting
protein [25].
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